Bliss GVS Pharma

June 2 (Reuters) - Bliss GVS Pharma Ltd BLIS.NS:

• BLISS GVS PHARMA LTD - RECEIVED AN INSPECTION CLOSURE REPORT FROM WORLD HEALTH ORGANIZATION

• BLISS GVS PHARMA - PALGHAR FACILITY HAS BEEN CONFIRMED TO BE IN COMPLIANCE WITH GOOD MANUFACTURING PRACTICES

Source text: ID:nBSE5nDDM8

Further company coverage: BLIS.NS

(([email protected];))

** Bliss GVS Pharma BLIS.NS stock rises more than 2% to 307.35 rupees, Anupam Rasayan India ANUY.NS down 1.5%

** Specialty chem firm ANUY to buy up to 74.2% Bliss stake, according to filing

** 45.8 mln shares, equivalent to 43.3% stake, for up to 13.7 bln rupees ($143.7 mln) from promoters and investors, 26% stake from public shareholders worth 8.29 bln rupees

** ANUY also has an option to acquire another 4.9% residual stake from sellers

** YTD, BLIS up about 88% and ANUY up around 2%

($1 = 95.3675 Indian rupees)

(Reporting by Vijay Malkar)

(([email protected];))

Feb 10 (Reuters) - Bliss GVS Pharma Ltd BLIS.NS:

• DEC-QUARTER CONSOL NET PROFIT 232.7 MILLION RUPEES

• DEC-QUARTER CONSOL REVENUE FROM OPERATIONS 2.18 BILLION RUPEES

Source text: ID:nBSEc1pHyZ

Further company coverage: BLIS.NS

(([email protected];))

Nov 6 (Reuters) - Bliss GVS Pharma Ltd BLIS.NS:

• BLISS GVS PHARMA LTD SEPT-QUARTER CONSOL NET PROFIT 272.5 MILLION RUPEES

• BLISS GVS PHARMA LTD SEPT-QUARTER CONSOL REVENUE FROM OPERATIONS 2.44 BILLION RUPEES

Source text: ID:nBSE7g0K3j

Further company coverage: BLIS.NS

(([email protected];;))

Oct 7 (Reuters) - Bliss GVS Pharma Ltd BLIS.NS:

• BLISS GVS PHARMA LTD - RECEIVES TAX DEMAND OF 166.9 MILLION RUPEES FROM TAX DEPARTMENT

Source text: ID:nNSE7qpMNB

Further company coverage: BLIS.NS

(([email protected];))

Sept 30 (Reuters) - Bliss GVS Pharma Ltd BLIS.NS:

• BLISS GVS PHARMA LTD - APPOINTS NARSIMHA SHIBROOR KAMATH AS CEO

Source text: ID:nBSE7sZhBb

Further company coverage: BLIS.NS

([email protected])

July 29 (Reuters) - Bliss GVS Pharma Ltd BLIS.NS:

• BLISS GVS PHARMA JUNE-QUARTER CONSOL NET PROFIT 430.4 MILLION RUPEES

• BLISS GVS PHARMA JUNE-QUARTER CONSOL REVENUE FROM OPERATIONS 2.07 BILLION RUPEES

Source text: [ID:]

Further company coverage: BLIS.NS

(([email protected];;))

July 2 (Reuters) - Bliss GVS Pharma Ltd BLIS.NS:

• BLISS GVS PHARMA LTD - GETS SHOW CAUSE FROM TAX DEPARTMENT OVER RECOVERY OF REFUND OF 66.4 MILLION RUPEES

Source text: ID:nBSE46BZkl

Further company coverage: BLIS.NS

(([email protected];;))

April 15 (Reuters) - Bliss GVS Pharma Ltd BLIS.NS:

• RISING PHARMA HOLDINGS GETS FINAL APPROVAL FROM USFDA FOR MESALAMINE SUPPOSITORIES

Source text: [ID:]

Further company coverage: BLIS.NS

(([email protected];;))

Jan 21 (Reuters) - Bliss GVS Pharma Ltd BLIS.NS:

• TO CONSIDER ISSUANCE OF SWEAT EQUITY SHARES

Source text: ID:nBSE7zTS7Z

Further company coverage: BLIS.NS

(([email protected];;))

** Shares of Bliss GVS Pharma BLIS.NS rise as much as 10.6%, last up 8.6% at 121.7 rupees

** Stock hits highest price since May 3

** Pharma co's June-quarter profit rose ~41% YoY

** Rival Torrent Pharmaceuticals' TORP.NS profit rose less than expected, sending its shares down on Wednesday

** Nifty Pharma index .NIPHARM, which BLIS is not part of, up 0.84%

** BLIS down ~1% YTD vs ~24% rise in pharma index, which includes rivals TORP and Mankind Pharma MNKI.NS

(Reporting by Varun Vyas in Bengaluru)

(([email protected]))

Feb 16 (Reuters) - Bliss GVS Pharma Ltd BLIS.NS:

• APPROVED AN INTERNAL RESTRUCTURING OF FOREIGN SUBSIDIARIES OF COMPANY

Source text for Eikon: ID:nBSE2BQhKM

Further company coverage: BLIS.NS

(([email protected];;))

Sept 7 (Reuters) - Bliss GVS Pharma Ltd BLIS.NS:

• ASSISTANT COMMISSION OF STATE TAX MAHARASHTRA INITIATED SEARCH ON SEPT 6 AT CERTAIN PREMISES OF CO

• NO IMPACT ON OPERATIONS, OR ANY OTHER ACTIVITIES OF CO EXPECTED AS OF NOW

Source text for Eikon: ID:nBSEqz51y

Further company coverage: BLIS.NS

(([email protected];;))

** Shares of Indian drugmaker Bliss GVS Pharma BLIS.NS fall as much as 6.87% to 91.55 rupees in sharpest intraday slide since May 12

** Co posted more than 43% slide in consol net profit at 146.9 mln rupees ($1.78 million) for the quarter ended June 30, while rev slipped more than 11% to 1.60 bln rupees

** Stock on track for fourth consecutive session of losses

** More than 400,00 shares changed hands by 10:09 a.m. IST, 0.8X 30-day avg

** BLIS has risen 28% so far this year

($1 = 82.4425 Indian rupees)

(Reporting by Hritam Mukherjee in Bengaluru)

(([email protected];))

Aug 1 (Reuters) - Bliss GVS Pharma Ltd BLIS.NS:

• INDIA'S BLISS GVS PHARMA JUNE-QUARTER CONSOL NET PROFIT 146.9 MILLION RUPEES VERSUS PROFIT 257.2 MILLION RUPEES

• BLISS GVS PHARMA JUNE-QUARTER CONSOL REVENUE FROM OPERATIONS 1.6 BILLION RUPEES VERSUS 1.89 BILLION RUPEES

Source text for Eikon: ID:nBSEjtHVV

Further company coverage: BLIS.NS

(([email protected];;))

** Shares of Bliss GVS Pharma BLIS.NS rise as much as 4.01% to 83.05 rupees, their highest level since May 11

** Co receives establishment inspection report from U.S. FDA indicating closure of inspection at its manufacturing facility in Maharashtra nFWN3863JQ

** U.S. drug regulator assigns classification of "voluntary active indicated" for the facility

** Stock's trading volume at around 647,000 shares as of 3:02 p.m. IST, nearly thrice the 30-day avg - Refinitiv data

** BLIS has risen over 10% in 2023 so far compared to 3% gains in pharma index .NIPHARM

(Reporting by Bharath Rajeswaran in Bengaluru)

(([email protected]; +91 9769003463;))